• Intravenous administration of guanethidine causes an initial transient fall in systemic arterial pressure followed by a pressor response. 1 " 3 The pressor effect is caused by release of norepinephrine. 1 " 7 The cause of the initial transitory depressor phase is not known. This fall in pressure is accompanied by a fall in peripheral resistance, 4 an increase in cardiac output, 4 and a positive inotropic effect on the heart. 8 McCubbin, Kaneko, and Page 2 showed that after treatment with reserpine, the intravenous administration of guanethidine resulted in sustained vasodilatation in the perfused hind limb. It may be that the vasodilatation appears transitory because it is antagonized by the pressor action of locally released norepinephrine. The experiments to be reported here were done in an effort to determine the mechanism of the acute vasodilator action of guanethidine.
Methods
A total of 3>S malo mongrel dogs (15 to 20 Kg.) were studied. Two types of experiments were performed. In the first, guanethidine was given intravenously in ascending doses to six intact dogs treated with reserpine. Reserpine (0.5 mg. ' Kg.) had been administered intraperitoneally daily for two days before the experiment. The cardiovascular effects of guanethidine were determined by measuring changes in cardiac output, systemic arterial pressure, and foreleg perfusion pressure when the blood flow into the brachial artery was held constant with a Sigmnmotor pump.
In the second type of experiments, tho effects of successive ascending doses of gunnethidine injected into the perfused brachial artery of four untreated dogs and four dogs treated with reserpine were studied. Attempts to block the vasodilator action of intra-arterinl guanethidine were made in 24 other dogs using intravenous infusions of atropine in 13, antihistnmines in 12 (ebJorprophenpyridamino was used in six and tripelennamino in six, and dichloroisoproterenol in all of them.
CARDIAC OUTPUT EXPERIMENTS
Six dogs treated with reserpine were lightly anesthetized with thiopental sodium and <riven gallnmine triethiodide. Intermittent positivepressure ventilation was provided with a fixedvolume respiratory pump through a cuffed endotracheal tube. Cardiac output was measured by the indicator-dilution technique with injections of indocyanine-green dye into the main pulmonary artery or the right ventricle through an intracardiae catheter. Dyed blood was drawn from a carotid artery through the cuvette of a Gilford densitometer. Blood pressures were measured with Statham strain gauges connected to a needle in the femoral artery and to the intracardiac catheter. Dye curves and blood pressures were recorded with n Riinborn direct-writing oscillograph.
(Juanethidine, 1, 2, and 4 nig./Kg., was administered through a cannula in the femoral vein. Blood pressures were recorded for 20 minutes following each injection. During this period, at least three dye curves were obtained. Appropriate precautions were taken to prevent errors from accumulation of background dye in the blood. s Twenty-five to 30 minutes were allowed between injections for blood pressure and cardiac output to return to control levels.
Mean blood pressures were obtained by electrical integration of the output of the strain gauges. Heart rate was counted from arterial pulse records. Cardiac output was calculated by the Stewart-Hamilton equations. 0 ' 10 Peripheral resistance was calculated by dividing mean arterial pressure in mm. Hg by cardiac output in L./ miii. and expressed in arbitrary units. Dose-response regressions were calculated according to methods described by Finney. 11 
PERFUSION EXPERIMENTS
These studies were done on 32 dogs anesthetized with chloralose (50 mg./Kg.) and urethane (500 mg./Kg.) mid on the six dogs in which card in c output was measured. The animals were placed on their right side, mid the right brachial artery was exposed high in the foreleg. Following intravenous injection of heparin sodium (5 mg./Kg.), the brachial artery was ligated, partially transected, and its distal segment was perfused with blood from the femoral artery with a Sigmamotor pump. The output of the pump was pulsatile and independent of systemic arterial pressure over the range encountered. The flow was adjusted initially so that mean pressure in the perfused artery ranged from 90 to 130 ram. Hg (average 105 mm. Hg). Inasmuch as animal size and foreleg resistance varied from animal to anima^ the flow rates ranged from 55 to 110 ml./min. (average 70 ml./min.). Once a flow rate was selected, it was maintained throughout the experiment. Perfusion pressure was measured through a side cannula connected to the tubing of the pump just before it entered the distal segment of the brachial artery. Systemic arterial blood pressure was recorded simultaneously.
Rectal temperatures recorded at 10-minute intervals showed little fluctuation. The shortness of the perfusion tubing, the stability of room tempt'raturc (22 to 25 C), and the use of a heating pad contributed to the stability of body temperature. The pressor responses of the perfused leg to asphyxia, carotid occlusion, or intra-arterinl injections of n variety of vasoconstrictor drugs were reproducible over a period of at lenst two hours.
The perfused forelegs were not denervated in the six dogs in which cardiac output was measured. In the remaining 32 animals, the right forelegs were denervated by cutting all visible nerves just below the brachial plexus. Intm-arterial injections of gumiethidine mid other test drugs were made into the distal tubing of the pump close to the brachial artery.
DRUGS*
Test drugs injected intra-arterially during the perfusion experiments were guanethidin,e, methacholine chloride, histamine phosphate, isoproterenol hydrochloride, glyceryl trinitrate, tyr/i-*Dichloroisoproterenol was supplied by Eli Lilly Research Laboratories. Guanethidine and tripelennamino were supplied by Ciba Pharmaceutical Products Inc. mine snlfate. Fresh dilutions were prepared for each experiment from commercial preparations. Two ogonists were given along with guanethidine to test the effect and selectivity of the antagonists. Guanethidine, methacholine, and glyceryl trinitrate were given before and after intravenous infusion of atropine sulfate; guanethidine, histamine, and glyceryl trinitrate were given before and after infusions of chlorprophenpyridamino maleate or tripelennamine hydrochloride; guanethidine, isoproterenol, and glyeeryl trinitrate were given before and after infusions of dichloroisoproterenol hydrochloride. The doses of glyceryl trinitrate were subiuiixininl. The "blocking" agents were not administered in the same order in all dogs. They were diluted in 50 to 100 ml. of isotonic saline and infused over periods of 10 to 15 minutes. The doses are described under "Eesults." All doses are expressed in terms of the salt.
Because the initial observations suggested that dichloroisoproterenol reduced the dilator effect of guanethidine, six experiments were done in which two doses of guanethidine and two doses of each of three agonists (isoproterenol, glyceryl trinitrnte, and methacholine) were given three times: once before dichloi'oisoproterenol, a second time nfter the intravenous infusion of dichloroisoproterenol, in a dose of 3.5 mg./Kg., and n thml time after the infusion of dichloroisoproterenol. in a dose of 7.0 mg./Kg.
Results

CARDIOVASCULAR RESPONSES TO INTRA-VENOUS ADMINISTRATION OF GUANETHIDINE TO SIX DOGS TREATED WITH RESERPINE
The average values of systemic arterial pressure, cardiac output, peripheral resistance, heart rate, stroke volume, and foreleg perfusion pressure, observed before and after intravenous guanethidine in doses of 1, 2, and 4 mg./Kg. giveu in ascending order, are in table 1. An abrupt fall in arterial pressure began 10 to 15 seconds after eacli injection and lasted less than one minute ( fig. 1) . A corresponding, but slightly delayed fall in pressure occurred in the perfused foreleg. The delay represents the time required for the drug to pass through the perfusion system. Systemic pressure returned to control levels following the initial depressor phase when small doses were given; it remained below control levels with larger doses (4 mg./ Kg.). There was no significant increase in heart rate or cardiac output, except during the depressor phase following the first dose. Stroke volume did not change.
There was ft linear regression of the response on the logarithm of the dose during the initial depressor phase with respect to the decreases in systemic arterial pressure and peripheral resistance (table 1) . Arterial pressure, peripheral resistance, and perfusion pressure remained at progressively lower levels with ascending doses of guanethidine after tho initial depressor phase (table 1) .
EFFECT OF SIX GRADED ASCENDING DOSES OF INTRA-ARTERIAL GUANETHIDINI ON THE PERFUSED FORELEG
An initial response (IR) was measured 20 seconds after guanethidine and a peak response (PR) was measured at the highest level of pressure reached after the drug (fig.
2). The average changes in perfusion pressure (IR and PR), observed with each dose in ascending order, are in parentheses.
In untreated dogs, small doses of 0.02, 0.1, and 0.5 mg. of guanethidine caused only increases in perfusion pressure (IR = +6.2, +14.2, +3.2, and PR = +7.0, +19.0, +40.0 mm. Hg, respectively). With higher doses of 1, 3, and 5 mg., an initial vasodilator response appeared, and the vasoconstrictor effect was reduced (IR = -10.2, -32.2, -38.5, and PR = +36.2, +18.5, +4.0 mm. Hg, respectively). In animals treated with reserpine, the six doses of guanethidine caused vasodilatation only (IR = -3.5, -2.7, -21.2, -24.0, -28.0, -27.2. and PR = -0.5, -0.2, -3.5, -10.0, -11.2, and -11.0 mm. Hg, respectively).
In untreated dogs, the constrictor effect of 0.1 mg. of intra-arterial tyramine (+94.0 mm. Hg) was reduced significantly (+19.0 mm. Hg) after successive injections of guanethidine ( fig. 3 ). The treated animals did not respond to tyramine (+2.0 mm. Hg).
EFFECT OF INTRAVENOUS ATROPINE, ANTIHISTAMINES, AND DICHLOROISO-PROTERENOL ON THE DILATOR ACTION OF INTRA-ARTERIAL GUANETHIDINE
Guanethidine was injected intra-arterially in successive doses of 2 or 3 mg. until a consistent dilator effect occurred in the perfused foreleg ( fig. 3 ). Intravenous infusions of atropine (0.2 to 0.4 mg./Kg.) and antihistamines (chlorprophenpyridamine 10 mg./Kg. or tripelennamine 2.5 mg./Kg.) did not reduce the dilator effect of guauethidine, although they antagonized the dilator effects of intra-arterial methacholine (0.05 to 2 /ng.) and intra-arterial histamine (2 to 3 /xg.), respectively (figs. 4 and 5). Intravenous dichloroisoproterenol (7 mg./Kg.) blocked the dilator effect of intra-arterial isoproterenol (0.25 to 2 /xg.), reduced significantly the magnitude and duration of the fall in pressure after guanethidine ( fig. 5, table 2 ), and did not alter the dilator effect of glyceryl trinitrate (6 to 20 /Ag.). The reduction in response to guanethidine after dichloroisoproterenol was only temporary, and the full response reappeared at a time when the dilator SAn is systemic arterial mean pressure; CO is cardiac output; E is peripheral resistance; HE is heart rate; SV is stroke volume; B is for control values before guanethidine; DP is for depressor phase immediately after guanethidine; PP represents observations made at the time of the maximum rise in pressure after the depressor phase.
The symbols * and t indicate the significance of the mean difference between the observations (DP, PP) and their corresponding control values (B). The symbol * indicates P <0.01 and the symbol t indicates P <0.05. The absence of a symbol indicates P >0.05.
The symbol t indicates a significant dose-rospoiise regression (P <0.05).
effect of isoproterenol was still antagonized. The effects of two doses of dichloroisoproterenol (3.5 and 7.0 mg./Kg.) on the dilator responses to guanethidine, isoproterenol, and two additional agonists (glyceryl trinitrate and methacholine) are in table 3. The larger dose of dichloroisoproterenol caused a greater reduction in the response to guanethidine, suppressed the effect of isoproterenol, and did not decrease significantly the responses to glyceryl trinitrate and methacholine.
Discussion
An excitatory effect on the heart and an inhibitory action on blood vessels were observed simultaneously during the transient depressor phase after intravenous guanethidine. Si 4 Various mechanisms were considered to explain these effects. Guanethidine may block sympathetic vasoconstrictor fibers and not the cardioexcitatory fibers. A reflex increase in cardiac output would result from
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vasodilatation. In these and in other experiments, 4 however, guanethidine had a direct vasodilator action on denervated forelegs; further, it increased cardiac output after ganglion-blocking drugs. 4 It appears that interference with sympathetic transmission is not the only mechanism which could explain these effects.
Another possibility is that guanethidine may stimulate beta adrenergic receptors in the heart and blood vessels directly. The work of Moran and Perkins 13 ' 14 and of Levy and Ahlquist 15 demonstrates that an excitatory action on the heart and an inhibitory action on blood vessels may be mediated by "functionally homologous receptors." In these experiments, treatment with reserpine prevented the increases in cardiac output and heart rate. Hence, the cardiac-stimulating effects, which were observed during the depressor as well as the pressor phase in untreated animals, 4 appear to be caused by a local release of cate- 
Changes in perfusion pressure (upper tracing in each frame) mid systemic arterial pressure (lower tracing in each frame) following intra-arterial injections of increasing doses of guanethidine into the perfused foreleg of dog A (untreated) and dog B (treated with reserpine). Vasoconstriction manifested by a rise in perfusion pressure is seen in tmiviai A and not in animal B. ^¥ith increasing dstses (1, .?, and .5 mg.), vasodikitation (futt in perfusion pressure) becomes apparent, and vasoconstriction is suppressed in dog A. Progressive vusoditatation without vasoconstriction is seen in dog B. The shar/) increases in perfusion pressure at the beginning of each response are injection artifacts.
cholaruiues and not by direct stimulation of adrenergic beta receptors.
The vasodilator effect of intravenous guanethidine was transient in untreated animals, 4 and became sustained when the pressor response was prevented by depletion of norepinephrine. Systemic arterial pressure remained significantly lower than the control levels after the initial depressor phase when 4 mg./ Kg. were given. Although corresponding values for peripheral resistance were not significantly lower than the control levels, vasodilatation was present since the same resistance in face of a fall in transmural pressure means loss of vascular tone. Further, dose-response regressions were linear with respect to the progressive fall in pressure and to the fall in resistance during and after the initial depressor phase.
Guanethidine, like reserpine, depletes the tissues of norepinephrine. Si n Its repeated intra-arterial administration enhanced its vasodilator action and decreased its vasoconstrictor effect in perfused denervated forelegs of dogs. Successive injections appeared sufficient to cause depletion of the norepinephrine which can be released from foreleg blood ves-sels. This is suggested by the reduction of the constrictor response to intra-arterial tyrainine. Reversal of the constrictor effect of guanethidine was observed consistently with the second or third injection of the same dose in untreated dogs. Once reversal of response was established, repeated injections of the same dose produced approximately the same depressor response ( fig. 3 ). This dilator action was local since it was observed in denervated forelegs after doses insufficient to cause a systemic effect.
In an attempt to explain the local vasodilatation, several possibilities were considered. The release of catecholamines from blood vessels did not appear to be involved since the vasodilator action of guanethidine was observed in animals treated with reserpine and in untreated animals when their response to tyraraine was suppressed. The possibility that the dilator action was caused indirectly by the local release of acetylcholine or histamine was considered. The results do not support this possibility. Intravenous infusions of atropine and antihistamines in doses sufficient to antagonize the dilator effects of intra-arterial methacholine and histamine did not reduce Effect of repeated intra-arterkd injections of the same dose of guanethidine (S mg.) on foreleg per fusion pressure (PP) and systemic arterial pressure (SAP). The vasoconstrictor effect seen with the first dose contrasts with the dilator effect of the two subsequent injections. The vasoconstrictor effect of inlru-ttrterial tyramine teas suppressed after gwinnthidine. <0.001 <0.001 Mech = methaeholine, Guan = guanethidine, NG = glyceryl trinitrnte, Hist = histamine, Iso = isoproteronol, Atr = atropine, Antihist = antihistamines, DCI = dichloroisoproterenol.
*The entries represent average values. The figures between parentheses represent the number of experiments. Tests were paired in that the dose of guanethidine and other vasodilator drugs used in any one test before the antagonist was duplicated after the antagonist.
• The response represents the area under the pressure-time curve following each injection of a dilator drug.
tThe P values represent the significance of the difference between the ratios of responses to guanethidine before and after the antagonists and the ratios of corresponding responses to the other agonists." Atropine (0.4 mg./Kg. intravenously) antagonized the vasodilator effect of intra-arterial methacholine and not that of intra-arterial guanethidine. The systemic pressor effect of guanethidine was augmented. This nuiy be attributed to the vagal blocking action of atropine and inhibition of baroreceptor reflexes. the responses to guanethidine. Further, the response to guanethidine tended to increase after atropine. Infusions of dichloroisoproterenol antagonized the dilator action of isoproterenol and reduced significantly the dilator effect of guanethidine. This reduction became more apparent when the area under the pressuretime curve was measured. This is because both the magnitude and duration of action of the drug were affected. A greater reduction in the dilator action of guanethidine was ob- Intravenous tripelennamine (2.5 mg./Kg.) blocked the vasodilator effect of intra-arterial histamine and not that of intra-arterial guaiiethidine and glyceryl trinitrate. Dichloroisoproterenol (7 mg./Kg. intravenously) blocked the vasodilator effect of intra-arterial isoproterenol and reduced the duration and magnitude of the dilator action of intraarterial guanethidine. The response to glyceryl trinitrate remained unchanged.
TABU 3
Effect of Dichloroisoproterenol (DC1) on the Responses to Guanethidine and Other
served when the dose of dichloroisoproterenol was doubled. It is unlikely that the reduction in response is a nonspecific depression of vascular smooth muscle responsiveness since the effects of glyceryl trinitrate and of methacholiue, which were used as internal controls, were not decreased by dichloroisoproterenol. This antagonist lias selective adrenergic blocking properties. Tt antagonizes certain inhibitory effects (vasodilatation) and certain excitatory effects (cardiac stimulation) but not the vasoconstrictor actions of sympathomimetic amines. 18 ' 18 ' 1T According to Ahlquist's classification of adrenergic receptors, 18 -19 dichloroisoproterenol is a beta adreuergieblocking drug. If one subscribes to this receptor theory, guanethidine would seem to produce vasodilatation, at least in part, by stimulation of beta receptors in blood vessel walls. Two observations are not consistent with such a conclusion. The first is that direct stimulation of the heart does not occur, and both the cardiac and peripheral actions mediated by beta receptors have always occurred simultaneously. The second is the dissimilarity in recovery from dichloroisoproterenol of the dilator effect of isoproterenol and guanethidine. The reason for the return of the full response to guanethidine at a time when the dilator effect of isoproterenol was still antagonized by dichloroisoproterenol is not clear.
Summary
The cardiovascular effects of intravenous guanethidine were measured in animals treated with reserpine. The action of intraarterial guanethidine was studied also in perfused forelegs of dogs. The following conclusions were reached:
1. There was no significant increase in cardiac output, heart rate, or systemic arterial pressure following intravenous guanethidine in treated animals; only sustained vasodilatation was observed.
2. The vasodilatatiou was caused by a local action of the drug on vascular smooth muscle. The dilatation became more pronounced following depletion of catecholamines with reserpiue and repeated administration of guanethidine.
3. The dilatation did not appear to be mediated through the release of catecholamlnes, histamine, or acetylcholine. It may have resulted, at least in part, from stimulation of beta adrenergic receptors or other "dilator receptors" which are blocked by dichloroisoproterenol.
